Free tool
FAERS Monitor: Relenza
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021036 or its brand name (Relenza, Zanamivir). Reports on generic versions are filed under their own applications.
Reports
2,525
Serious
1,595
63% of reports
Hospitalization
390
Death reported
250
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- abnormal behaviour399
- overdose395
- drug exposure during pregnancy244
- hallucination159
- drug exposure via breast milk123
- no adverse event117
- delirium115
- loss of consciousness104
- pyrexia100
- death70
- dyspnoea69
- aggression57
- depressed level of consciousness56
- altered state of consciousness55
- pneumonia54
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2005 | 8 |
| 2006 | 6 |
| 2007 | 113 |
| 2008 | 143 |
| 2009 | 933 |
| 2010 | 312 |
| 2011 | 317 |
| 2012 | 91 |
| 2013 | 60 |
| 2014 | 114 |
| 2015 | 78 |
| 2016 | 77 |
| 2017 | 32 |
| 2018 | 49 |
| 2019 | 94 |
| 2020 | 44 |
| 2021 | 24 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,634 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug exposure via breast milkSignal | 123 | 1053.9 | 877.3 | 113,941 |
| abnormal behaviourSignal | 399 | 84.7 | 77.4 | 32,665 |
| drug exposure during pregnancySignal | 244 | 60.2 | 53.4 | 14,065 |
| deliriumSignal | 115 | 27.7 | 23.2 | 2,928 |
| altered state of consciousnessSignal | 55 | 21.2 | 16.3 | 1,037 |
| hallucinationSignal | 159 | 17.6 | 15.1 | 2,478 |
| overdoseSignal | 395 | 15.3 | 14.0 | 5,302 |
| depressed level of consciousnessSignal | 56 | 11.8 | 9.1 | 543 |
| aggressionSignal | 57 | 9.5 | 7.3 | 425 |
| loss of consciousnessSignal | 104 | 6.8 | 5.6 | 508 |
| no adverse eventSignal | 117 | 5.4 | 4.5 | 416 |
| pyrexiaSignal | 100 | 2.4 | 2.0 | 82 |
| pneumonia | 54 | 1.4 | 1.1 | 6 |
| dyspnoea | 69 | 1.0 | 0.8 | 0 |
| death | 70 | 0.7 | 0.5 | 11 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.